Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
3.740
+0.120 (3.31%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $139.06 million as of September 25, 2026. Its market cap has increased by 25.12% in one year.
Market Cap
139.06M
Enterprise Value
429.06M
1-Year Change
25.12%
Ranking
Category
Stock Price
$3.74
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $139.06M, an increase of 200.25%. That is a compound annual growth rate of 16.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 139.06M | -39.18% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 140.10M |
| Tenaya Therapeutics | 139.02M |
| Tiziana Life Sciences | 134.48M |
| Kazia Therapeutics | 134.02M |
| Caribou Biosciences | 134.01M |
| Unicycive Therapeutics | 133.98M |
| TuHURA Biosciences | 133.83M |
| Neumora Therapeutics | 132.11M |